Reddit Posts
Analysts' top-rated penny stocks to add to your watchlist
These 2 ‘Strong Buy’ Stocks Could Soar to $25 (Or Higher), Says Piper Sandler
These 2 ‘Strong Buy’ Penny Stocks Could Soar to $25 (Or Higher), Says Piper Sandler
IMUX --- $28 Price Target by Piper Sandler
Feetr Data Dump: IFRX FRGT IMUX RNAZ ATNF MGIH SECO
My IMUX calls yesterday. 5 Analysts have price targets between $5 and $39 for the stock in 2023.
IMUX stock climbs as Wedbush initiates with bullish view on lead asset (NASDAQ:IMUX)
$IMUX this the next play I feel good about it's vaccine season and these medical stocks explode on any good news.
💰💰💰Good morning! #premarket #watchlist 11/17 $ARDX -positive FDA panel vote on kidney disease treatment, $CTMX -Regeneron and CytomX Announce Strategic Research Collaboration, $IMUX -Immunic Reports New Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium
IMUX shorts over reaction. If they don’t cover Monday 4am, they will trapped. Huge runner for Monday to Friday why we drop 77% due to one phase 1 trial when the lead trails of Phase 2 and 3 are intact! 🤷🏻♂️🙈 150 million cash!
2022-10-21 Better Tasting Crayons (Mathematically derived options plays)
A stock pick for the turd-miners
$MIGI $IMNX, $NURO, $JUPW, $VLSK, $APDN --Positive Momentum Expected Today
💰Good morning! #premarket #watchlist 06/2 $MF -china pump, $IMMP -potential secondary offering, $BTOG - Signs Letter of Intent to Purchase 850 Bitcoin Miners, $IMUX - Reports Top-Line Data from Phase2. Check it all in Realtime Stock Screener!
💰Good morning! #premarket #watchlist 06/2 $MF -china pump, $IMMP -potential secondary offering, $RPTX -Worldwide License and Collaboration Agreement with #Roche, $CHWY -First Quarter 2022 Financial Results, $IMUX - Reports Top-Line Data from Phase2. Check it all in Realtime Stock Screener!
💰Good morning! #premarket #watchlist 06/2 $MF -china pump, $IMMP -potential secondary offering, $RPTX -Worldwide License and Collaboration Agreement with #Roche, $CHWY -First Quarter 2022 Financial Results, $IMUX - Reports Top-Line Data from Phase2. Check it all in Realtime Stock Screener!
💰Good morning! #premarket #watchlist 06/2 $MF -china pump, $IMMP -potential secondary offering, $RPTX -Worldwide License and Collaboration Agreement with #Roche, $CHWY -First Quarter 2022 Financial Results, $IMUX - Reports Top-Line Data from Phase2.
IMUX: Phase 2 trial data very good. Low float, no surge yet
Luokung Technology Corp ($LKCO) - Luokung Technology Corp., through its subsidiaries, provides location-based services and mobile application products for long distance travelers in the People's Republic of China
Mentions
I’ve been holding IMUX for a while. They have some great things in the works and I believe in the stock in the long term.
What do you think guys abot IMUX & ACET ?
Thoughts on IMUX? Forecast is $10 per share
IMUX is grinding up. If you like reading indepth DDs check my history. Crazy potential and big institutional accumulation as well as coordinated buying between ceo, coo and cfo as well as an upcoming catalyst in the next few months
ECTRIMS was a turning point. Vidofludimus calcium showed stat sig disability improvement + slowing progression in progressive MS with a safety profile nearly placebo-like. That’s unheard of in MS. Add to that: • 📑 Selected for Best of ECTRIMS 2025 • 🧬 Nurr1 activation = first-in-class neuroprotection • 🛡️ IP protection until 2041 • 💰 Institutions own >50% (Aberdeen, BVF, Soleus, Vanguard, etc.) Now the real focus → the end-of-Phase 2 FDA/EMA meeting later this year. A positive outcome = IMUX moves to Phase 3 PMS + already has two fully enrolled Phase 3 RMS trials. This de-risks the program massively and gives IMUX leverage in buyout/partnership talks. 📊 Buyout Valuation Range (based on comps in MS & autoimmune): • Low case: $15/share ($1.5B) • Base case: $30–50/share ($3–5B) with CVRs for milestones • High case: $70–100/share ($7–10B, competitive bidding) At today’s ~$0.80, the risk/reward is asymmetric. The science is validated, institutions are loading, and Big Pharma won’t let a blockbuster-ready oral MS drug with 16 years of patent life just sit around.
Are there any people among you who have information on IMUX and when do you think it will explode, if so?
Up 8% on IMUX since Friday, should see more buys tomorrow, with Wednesday being a big day due to multiple posters being presented at ECTRIM.
oh other thing i forgot to mention re. IMUX is the interesting tute accumulation of 9.99% each, mikey goes into [more detail in his DD](https://www.reddit.com/r/pennystocks/s/6o3SCCaWtH) if anyone’s interested.
Bought 20k IMUX shares today, very bullish on their presentation at ECTRIM next week as well as the investor conference they’re attending right now, plus the phase 2 data looked pretty promising.
Anyone have any opinions on IMUX? Is owning this regarded?
Yep. IMUX +5.4%, EDGM +25%, AGL +1%, UAMY (not really a penny anymore but still holding) +4.9%. CAPC down 8.3% but my position there is small. Overall not a bad day Some of this is strategy, plenty of it is blind luck ngl
Some guy on here posted a bunch of DD. Comments tore him a new one. I then asked copilot if it was a good move. It said it had just gotten some patten approval. So I went for it. The news created an uptick. What I’m starting to learn is if there is just a little buzz, stock is trending on Reddit, and it makes it to the top ten on penny stock mentions. I did the same the UAV, and open door. Made 4k with open door and 4k with UAV. Now I made 4 k profit with IMUX. My strategy is to buy long calls to give me wiggle room to not loose so much.
Props to whoever called out IMUX yesterday. Not that it’s starting yet, but just saw the news about their patent approval. Not that that’s any kind of smoking gun that it’ll take off, but still looks good to call out a stock <24 hours before unexpected positive news
I have been holding for over a year and my average is currently $0.90. In recent months, I bought more shares to lower my average. I had hoped that the good data would have pushed the stock price closer to $2. However, I am very patient and believe in the leadership team’s game plan. If you follow IMUX closely, it’s clear which direction they are heading. I also hope they become more visible on Reddit so more people might step in. That said, the fact that institutions are already investing at this stage is extremely bullish!
IMUX will some have potential by the beginning of next year Any input on BONK? Hearing high ceiling potential. Curious if anyone has heard anything?
IMUX 🚀🚀🚀 Under $1 biotech that nobody is talking about. Institutions (BVF, Avidity, RTW, Aberdeen, Vanguard, even Morgan Stanley) are LOADING. Insiders bought shares in June (CEO + team putting $$ in). Their lead drug is in Phase 3 trials for multiple sclerosis. Already crushed Phase 2, showing brain protection (slowing atrophy). Huge upside if Phase 3 hits in 2026. Peak sales potential = billions. Market cap right now? Only ~$80M. Catalyst coming up this month → ECTRIMS 2025 (Sept 24–26) with 5 presentations, including a late-breaking poster + oral. This is where big pharma plays (Roche, Novartis, Sanofi, Biogen) will be watching. Perfect buyout bait. Yes, cash is tight (7 months runway), but that’s biotech. Dilution can happen, but institutions don’t pile in for pennies… they’re here for a potential 10x–30x move if data hits. Not financial advice, but I’m calling it → IMUX is a sleeping giant. Either buy now or cry later when it moons.
I see that IMUX has been mentioned on this forum before, and I noticed it is taking part in the upcoming Multiple Sclerosis conference, the 24-26th of September, with what they believe to be strong data. Is there a good chance it will run the coming days, if they have any additional news? Like a partnership or licensing agreement? They said this at their earnings on the 7th of August: "Based on the strength of the data, a total of five abstracts have been selected for presentation at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in September, including one oral presentation and one late-breaking poster – a major achievement for the company." It has been up and down a bit the past days, but end of month seems like a good time to push for good news.
Currently looking at Prof Amato and any affiliation with IMUX. She seems to be strong proponent of MS progression treatment (indication for 838) and will be speaking at ECTRIMS in Sep. (https://pag.virtual-meeting.org/congrex/ectrims2025/en-GB/pag/presentation/375467) ECTRIMS is the largest MS conference in EU. Perhaps institutions are positioning for data/updates from IMUX? No confirmation but highly likely IMUX will present there given past presentations at high profile conferences. Still researching
https://www.sec.gov/edgar/search/#/ciks=0001280776&entityName=IMMUNIC%252C%2520INC.%2520(IMUX)%2520(CIK%25200001280776)
Several 13G filings in August reveal that big funds are accumulating significant stakes: • Nantahala Capital Management, LLC – 10.63M shares (~9.99%) • Alyeska Investment Group, L.P. – 9.49M shares (~9.9%) • BIOTECHNOLOGY VALUE FUND LP – 6.27M shares (~6.4%) • Avidity Partners Management LP – 5.62M shares (~5.9%) This level of concentrated institutional ownership is unusual for a biotech and can make strategic partnerships or even an acquisition easier for a big pharma company. Combined with the strong pipeline marketing by management, increased conference presence, and recent clinical updates, the overall picture looks very bullish for IMUX.
Over the past few weeks, Immunic (IMUX) has quietly been stacking up positive developments: • Data strength vs. big pharma: Vidofludimus calcium (IMU-838) has shown results in MS that compare favorably — and in some ways exceed — those from Roche’s rival drug in similar patient populations. • New scientific angles: Recent peer-reviewed publications point to potential expansion into other autoimmune diseases, including type 1 diabetes, by boosting regulatory T cells (Tregs) while reducing harmful immune activation. • Institutional confidence building: Aberdeen disclosed an 8.6% stake and now 683 Capital Management has filed owning 9.9%. That’s two sizable institutional holders entering within weeks of each other. • Insider alignment: There was insider buying in June, signaling management’s own confidence in the company’s trajectory. • Pipeline quietly expanding: A new U.S. patent filing for deuterated RORγ inverse agonists adds another potential long-term value driver beyond IMU-838. Yes, the market hasn’t woken up yet — the share price is still hugging the $1 zone — but the ingredients for a serious re-rating are coming together: strong data, expanding IP, insider alignment, and heavyweight institutions building positions before major catalysts hit.
Why does nobody seem to buy IMUX? It sounds like a great opportunity...
Was able to average down on IMUX I’ll keep buying sub 95 in larger lots, smaller batch buys until 1.20
Going after hype quick wins then taking gains and putting in IMUX
$NCNA because it’s cheap and no one sells at $0,06. The only way is up $IMUX because it’s also cheap and good News is up hand which Will bull this $MBOT because it is the AI for doctors (took them jobs) $OPEN because other people are in so deep, they can’t afford to cash out $GPRO because it is affordable for everyone
$NCNA because it’s cheap and no one sells at $0,06. The only way is up $IMUX because it’s also cheap and good News is up hand which Will bull this $MBOT because it is the AI for doctors (took them jobs) $OPEN because other people are in so deep, they can’t afford to cash out $GPRO because it is affordable for everyone, they are launching new products and subscriptions are booming!
I have strong believes in $NCNA $IMUX $MBOT and even $OPEN the trick is not to cash out on a short term but let it grow over time. Just use the money for these stocks that you can afford to miss out on for a while and you Will be rewarded.
IMUX if you’re willing g to wait until end of 26
Loading up on IMUX at the moment. Building a strong base for a large pop in 26
$NCNA and $IMUX for its potential on the long term, $GPRO and MBOT for the short term pump, $OPEN for the "why not, see where it goes"
Very high on $IMUX, I keep buying when it dips below a dollar, thinking 50% gains by EOY, $5 in 2026
Fuck it, I’m in. Check out my DD on IMUX
Focus on a topic, find something that has the ability to run up with sound fundamentals, take the gamble when it’s easy, diversify plan to hit 1 out of 10 Check out my IMUX post on smallstreetbets.
IMUX still has a strong price target https://www.gurufocus.com/news/2945145/immunic-imux-maintains-buy-rating-with-10-price-target-imux-stock-news
IMUX https://ir.imux.com/2025-06-24-Immunic-Reports-New,-Positive-Long-Term-Open-Label-Extension-Data-From-Phase-2-EMPhASIS-Trial-of-Vidofludimus-Calcium-in-Relapsing-Remitting-Multiple-Sclerosis
IMUX with some strong insider buys https://www.secform4.com/insider-trading/1280776.htm
It’s a biotech stock. Look at NUVB… came out last week with FDA approval of a lung cancer drug and the stock isn’t performing even with strong price and buy analysis. IMUX is another one with super huge news for super positive MS drug and again stock isn’t bouncing in the great news. I could go on and on when it comes to these biotech stocks.
It will move. It’s a good one to hold for a bit. IMUX is the same. Both NUVB and IMUX have had some incredible news and we should see good gains sooner rather than later.
The best stock under a dollar if volume would pick up. Here are just a few of the catalysts that should be moving this stock. I’m in for the long haul with this one but feel as though it could boom real soon. https://www.gurufocus.com/news/2909840/imux-completes-enrollment-for-phase-3-trials-in-multiple-sclerosis-imux-stock-news https://www.gurufocus.com/news/2910201/immunic-imux-receives-continued-buy-rating-from-d-boral-capital-imux-stock-news https://www.stocktitan.net/news/IMUX/immunic-announces-completion-of-enrollment-for-both-phase-3-ensure-9iaq7ely10fj.html
IMUX in the news again with some nice price predictions and such. Lots of good news over the last couple of weeks for this company https://www.defenseworld.net/2025/06/11/immunic-inc-nasdaqimux-given-average-rating-of-buy-by-brokerages.html
IMUX news just keeps coming https://www.defenseworld.net/2025/06/09/millennium-management-llc-has-580000-stake-in-immunic-inc-nasdaqimux.html
What’s everyone holding long term? I’m still holding IMUX… so much positive news over the last days, weeks, and months that I feel like it’s a strong play. Interested in what others are holding long term
They are presenting at 6 different conferences this month. Schedule is in the article below. https://www.stocktitan.net/news/IMUX/immunic-to-participate-in-investor-scientific-and-industry-qa72t6zks4fw.html
I’m still holding IMUX! Not sure why but I can’t bring myself to sell it… hopefully all the recent news will help pump it over the next couple of weeks. Has a ton of positives and a good price prediction, and insiders are still buying.
IMUX might be a good play. Lots of good news https://www.stocktitan.net/news/IMUX/immunic-announces-completion-of-enrollment-for-both-phase-3-ensure-9iaq7ely10fj.html https://www.nasdaq.com/articles/insider-purchase-chief-financial-officer-imux-buys-45000-shares https://www.gurufocus.com/news/2905949/immunic-inc-announces-closing-of-oversubscribed-65-million-underwritten-public-offering-imux-stock-news
$IMUX just dropped phase 3 trial news check it out
IMUX, positive phase 2 for MS news at 0630.
Same, only penny stock I’m invested in at the moment is IMUX. Took at look at these posted though, maybe there’s something there.
Your post with title "What do you think of IMUX" has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
IMUX VOLUME ON POINT YESTERDAY AND INTO TODAY… let’s go…..!!
Immunic “IMUX” is my favorite Robinhood stock this week.
IMUX Looks juicy to me. Any thoughts? I have some friends that are talking 12X returns
STI / IMUX / ENVB / PRZO watch them closely….OCGN have good options on 1$ and feels supported
$BMR and $IMUX are my two tickets this morning do your research make some money folks :)
$IMUX first phase of the new plan will take place Monday should shoot up well into the 2 range. Read the news carefully do your own DD. But it’s a winner for this next week might see 3 even a spike to ten is possible.
Gosh man. With that amount of money you could just ride the biggest daily jump stock, in and out within hours and make at least a couple thousands profit. For example check $SGD and $IMUX this morning.
For me it’s WINT. Read their journal articles in major cardiac medical journals, look up posts from cardiac researchers on Twitter. They had 3 successful phase 2 trials and are waiting on partnerships for phase 3 trials for a drug that could actually be huge. IMUX in a similar boat but it already ran recently so I’m not sure if it’s a good entry now.
1) Buying more WINT, very confident about that one. 2) I've been watching is BTTX since they just got FDA approval of their prescription diabetes/fatty liver disease app, but the market did not react the way I expected to the approval because the company's financials suck, so I haven't bought in yet. 3) Watching IMUX for a re-entry point. I bought at 1.45 and sold at 2.90, but hoping for a re-entry if it drops to near 2.00 ever
Still in on IMUX. Waiting to see how it pulls today before exiting. I think it still has room.
$IMUX is up 55% since I posted it here on Tuesday. Time to take some profits!
IMUX starting strong this morning.
OK, as expected, IMUX is up 10% today. Don't forget who told you about it yesterday :)
$IMUX on watch -- [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-135603450.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-135603450.html)
IMUX +15% on more than 3x volume... Looks well positioned for tomorrow.
Guys, check out IMUX --- Piper Sandler gave it $28 price target --- [https://finance.yahoo.com/news/2-strong-buy-penny-stocks-135603450.html](https://finance.yahoo.com/news/2-strong-buy-penny-stocks-135603450.html)
I am a bot. You submitted a picture of a banned ticker, IMUX. The market cap of IMUX is **87,829,040** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
FFIE , BBAI , JZXN , TRKA AND IMUX are the ones im looking at today!